Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
484
NCT01473810
Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant
Phase: Phase 1/2
Role: Collaborator
Start: Nov 30, 2011
Completion: Mar 31, 2012
NCT02998996
Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU
Role: Lead Sponsor
Start: Sep 30, 2016
Completion: Jun 1, 2017
NCT03437304
Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU in Older Adults
Start: Feb 9, 2018
Completion: Nov 30, 2018